Smoking and lung cancer: future research directions.
The aim of future research in this area is to provide the mechanistic understanding and the tools for effective prevention, early diagnosis, and therapy of lung cancer. With the established causal link between cigarette smoking and the risk of developing lung cancer, the most effective prevention is certainly not to smoke. A much better mechanistic understanding of lung cancer and its variability will support the development and evaluation of potentially reduced risk products for those who maintain smoking as well as for the development of early diagnostic tools and targeted therapies. Because of the complexity of lung cancer and the long duration for its development, nonclinical and clinical research efforts need to complement each other. Recent promising advances in this research area are the understanding of the interaction between genotoxic and epigenetic effects of smoking, the development of laboratory animal models for lung tumorigenesis by smoke inhalation, the unraveling of molecular pathways and signatures in clinical lung cancer research useful for developing diagnostic tools and therapeutic approaches, and the first successful therapy for lung cancer - although less suitable for smokers. The above - in combination with emerging data sets from explorative non-clinical and clinical studies as well as improved modeling approaches - are setting the stage for accelerated progress towards developing successful early diagnostic tools and therapies as well as for the assessment of new consumer products with potentially reduced risk.
Haussmann
Hans-Juergen
HJ
Roesrath, Germany. HansJ.Haussmann@TOnline.de
D000280:Administration, Inhalation; D000818:Animals; D000830:Animals, Laboratory; D014408:Biomarkers, Tumor / Q000378:metabolism; D035843:Biomedical Research / Q000639:trends*; D015197:Carcinogenicity Tests; D004195:Disease Models, Animal; D008168:Lung / Q000187:drug effects / Q000378:metabolism; D008175:Lung Neoplasms / Q000209:etiology* / Q000378:metabolism; D012907:Smoking / Q000009:adverse effects*
D014408:Biomarkers, Tumor